1,618 Shares in Astera Labs, Inc. $ALAB Purchased by MOR Wealth Management LLC

MOR Wealth Management LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, Holdings Channel reports. The fund purchased 1,618 shares of the company’s stock, valued at approximately $782,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Eurizon Capital SGR S.p.A. bought a new position in shares of Astera Labs in the fourth quarter valued at approximately $18,708,000. Swedbank AB boosted its holdings in shares of Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. bought a new stake in Astera Labs during the 4th quarter worth approximately $499,000. Revere Asset Management Inc bought a new stake in Astera Labs during the 4th quarter worth approximately $589,000. Finally, Banque Cantonale Vaudoise increased its holdings in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after purchasing an additional 3,229 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director owned 3,970 shares in the company, valued at $1,237,965.10. This represents a 69.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is currently owned by company insiders.

Astera Labs Stock Up 9.8%

ALAB stock opened at $310.40 on Friday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market cap of $53.85 billion, a P/E ratio of 153.66 and a beta of 3.77. The business has a fifty day moving average of $330.74 and a 200-day moving average of $254.36.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. Royal Bank Of Canada lifted their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Susquehanna increased their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. TD Cowen cut their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a report on Wednesday, August 5th. Finally, Evercore reiterated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $348.33.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.